These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 23486338)
21. Overexpression of STMN1 is associated with the prognosis of meningioma patients. Wang H; Li W; Wang G; Zhang S; Bie L Neurosci Lett; 2017 Jul; 654():1-5. PubMed ID: 28625575 [TBL] [Abstract][Full Text] [Related]
22. Abundant immunohistochemical expression of dopamine D2 receptor and p53 protein in meningiomas: follow-up, relation to gender, age, tumor grade, and recurrence. Trott G; Pereira-Lima JF; Leães CG; Ferreira NP; Barbosa-Coutinho LM; Oliveira MC Braz J Med Biol Res; 2015 May; 48(5):415-9. PubMed ID: 25742638 [TBL] [Abstract][Full Text] [Related]
23. Does protein expression predict recurrence of benign World Health Organization grade I meningioma? Kärjä V; Sandell PJ; Kauppinen T; Alafuzoff I Hum Pathol; 2010 Feb; 41(2):199-207. PubMed ID: 19801161 [TBL] [Abstract][Full Text] [Related]
24. Expression of p40 (∆Np63) protein in meningiomas, an unexpected finding: immunohistochemical study and evaluation of its possible prognostic role. Guadagno E; Del Basso De Caro M; Pignatiello S; Sciammarella C; Solari D; Cappabianca P; Maiuri F; Dones F J Neurooncol; 2016 Sep; 129(3):405-413. PubMed ID: 27394131 [TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment. Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521 [TBL] [Abstract][Full Text] [Related]
26. De novo and secondary anaplastic meningiomas: a study of clinical and histomolecular prognostic factors. Peyre M; Gauchotte G; Giry M; Froehlich S; Pallud J; Graillon T; Bielle F; Cazals-Hatem D; Varlet P; Figarella-Branger D; Loiseau H; Kalamarides M Neuro Oncol; 2018 Jul; 20(8):1113-1121. PubMed ID: 29216385 [TBL] [Abstract][Full Text] [Related]
27. Anaplastic meningioma: progression from atypical and chordoid morphotype with morphologic spectral variation at recurrence. Bollag RJ; Vender JR; Sharma S Neuropathology; 2010 Jun; 30(3):279-87. PubMed ID: 19780983 [TBL] [Abstract][Full Text] [Related]
28. Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas. Barresi V; Cerasoli S; Vitarelli E; Tuccari G Acta Neuropathol; 2007 Aug; 114(2):147-56. PubMed ID: 17594108 [TBL] [Abstract][Full Text] [Related]
29. Early recurrences in histologically benign/grade I meningiomas are associated with large tumors and coexistence of monosomy 14 and del(1p36) in the ancestral tumor cell clone. Maillo A; Orfao A; Espinosa AB; Sayagués JM; Merino M; Sousa P; Lara M; Tabernero MD Neuro Oncol; 2007 Oct; 9(4):438-46. PubMed ID: 17704362 [TBL] [Abstract][Full Text] [Related]
30. High p-mTOR expression is associated with recurrence and shorter disease-free survival in atypical meningiomas. Barresi V; Lionti S; La Rocca L; Caliri S; Caffo M Neuropathology; 2019 Feb; 39(1):22-29. PubMed ID: 30511495 [TBL] [Abstract][Full Text] [Related]
31. Correlation of MTAP Immunohistochemistry With CDKN2A Status Assessed by Fluorescence In Situ Hybridization and Clinicopathological Features in CNS WHO Grade 2 and 3 Meningiomas: A Single Center Cohort Study. Sasaki S; Takeda M; Hirose T; Fujii T; Itami H; Uchiyama T; Morita K; Matsuda R; Yamada S; Nakagawa I; Ohbayashi C J Neuropathol Exp Neurol; 2022 Jan; 81(2):117-126. PubMed ID: 34897475 [TBL] [Abstract][Full Text] [Related]
32. An immunohistochemical study of HER2 expression in meningioma and its correlation with tumor grade. Mahzouni P; Movahedipour M Pathol Res Pract; 2012 Apr; 208(4):221-4. PubMed ID: 22420924 [TBL] [Abstract][Full Text] [Related]
33. Gain of chromosome arm 1q in atypical meningioma correlates with shorter progression-free survival. Jansen M; Mohapatra G; Betensky RA; Keohane C; Louis DN Neuropathol Appl Neurobiol; 2012 Apr; 38(2):213-9. PubMed ID: 21988727 [TBL] [Abstract][Full Text] [Related]
35. Pathological significance of epidermal growth factor receptor expression and amplification in human gliomas. Zhao LL; Xu KL; Wang SW; Hu BL; Chen LR Histopathology; 2012 Oct; 61(4):726-36. PubMed ID: 22978472 [TBL] [Abstract][Full Text] [Related]
36. Karyopherin a2 and chromosome region maintenance protein 1 expression in meningiomas: novel biomarkers for recurrence and malignant progression. Gousias K; Niehusmann P; Gielen GH; Simon M J Neurooncol; 2014 Jun; 118(2):289-296. PubMed ID: 24664371 [TBL] [Abstract][Full Text] [Related]
37. The expression of fatty acid metabolism-associated proteins is correlated with the prognosis of meningiomas. Jiang J; Lin C; Liu N; Zhang Z; Sun Y; Fang X; Qi J APMIS; 2013 Oct; 121(10):997-1003. PubMed ID: 23879478 [TBL] [Abstract][Full Text] [Related]
38. Genetic changes with prognostic value in histologically benign meningiomas. Barbera S; San Miguel T; Gil-Benso R; Muñoz-Hidalgo L; Roldan P; Gonzalez-Darder J; Cerda-Nicolas M; Lopez-Gines C Clin Neuropathol; 2013; 32(4):311-7. PubMed ID: 23442303 [TBL] [Abstract][Full Text] [Related]
39. AKT2 expression in histopathologic grading and recurrence of meningiomas. Wang Q; Fan SY; Qian J; Wang JY; Lu YC; Hu GH; Luo C Eur J Surg Oncol; 2014 Sep; 40(9):1056-61. PubMed ID: 24656454 [TBL] [Abstract][Full Text] [Related]
40. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions? Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]